Cargando…
Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report
Polyostotic fibrous dysplasia (FD) associated to McCune-Albright Syndrome (MAS) often leads to fractures, deformities, and bone pain resulting in bad quality of life. Parenteral bisphosphonates have been used in children and adolescents to improve these symptoms with few adverse effects. We evaluate...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952807/ https://www.ncbi.nlm.nih.gov/pubmed/20976302 http://dx.doi.org/10.1155/2010/432060 |
_version_ | 1782187808233881600 |
---|---|
author | Aragão, Ana Luiza Andrade Silva, Ivani Novato |
author_facet | Aragão, Ana Luiza Andrade Silva, Ivani Novato |
author_sort | Aragão, Ana Luiza Andrade |
collection | PubMed |
description | Polyostotic fibrous dysplasia (FD) associated to McCune-Albright Syndrome (MAS) often leads to fractures, deformities, and bone pain resulting in bad quality of life. Parenteral bisphosphonates have been used in children and adolescents to improve these symptoms with few adverse effects. We evaluated the response to oral Alendronate in a girl with severe MAS FD and observed improved quality of life with reduction of bone pain. |
format | Text |
id | pubmed-2952807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29528072010-10-25 Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report Aragão, Ana Luiza Andrade Silva, Ivani Novato Int J Pediatr Endocrinol Case Report Polyostotic fibrous dysplasia (FD) associated to McCune-Albright Syndrome (MAS) often leads to fractures, deformities, and bone pain resulting in bad quality of life. Parenteral bisphosphonates have been used in children and adolescents to improve these symptoms with few adverse effects. We evaluated the response to oral Alendronate in a girl with severe MAS FD and observed improved quality of life with reduction of bone pain. BioMed Central 2010 2010-09-21 /pmc/articles/PMC2952807/ /pubmed/20976302 http://dx.doi.org/10.1155/2010/432060 Text en Copyright © 2010 Aragão and Silva. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Aragão, Ana Luiza Andrade Silva, Ivani Novato Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report |
title | Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to
McCune-Albright Syndrome in a Child: A Case Report |
title_full | Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to
McCune-Albright Syndrome in a Child: A Case Report |
title_fullStr | Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to
McCune-Albright Syndrome in a Child: A Case Report |
title_full_unstemmed | Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to
McCune-Albright Syndrome in a Child: A Case Report |
title_short | Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to
McCune-Albright Syndrome in a Child: A Case Report |
title_sort | oral alendronate treatment for severe polyostotic fibrous dysplasia due to
mccune-albright syndrome in a child: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952807/ https://www.ncbi.nlm.nih.gov/pubmed/20976302 http://dx.doi.org/10.1155/2010/432060 |
work_keys_str_mv | AT aragaoanaluizaandrade oralalendronatetreatmentforseverepolyostoticfibrousdysplasiaduetomccunealbrightsyndromeinachildacasereport AT silvaivaninovato oralalendronatetreatmentforseverepolyostoticfibrousdysplasiaduetomccunealbrightsyndromeinachildacasereport |